How has been the historical performance of the Natco Pharma?
Natco Pharma has shown significant growth from March 2020 to March 2025, with net sales increasing from Rs 1,915 crore to Rs 4,429.50 crore and profit after tax rising from Rs 458.10 crore to Rs 1,883.40 crore, indicating strong profitability and operational efficiency. The company's earnings per share also grew from Rs 25.32 to Rs 105.33 during this period.
Answer:The historical performance of Natco Pharma shows a significant upward trend in net sales and profitability over the years, culminating in the fiscal year ending March 2025.Breakdown:
Natco Pharma's net sales have consistently increased from Rs 1,915.00 crore in March 2020 to Rs 4,429.50 crore in March 2025, reflecting a robust growth trajectory. Total operating income followed a similar pattern, rising from Rs 1,915.00 crore in March 2020 to Rs 4,429.50 crore in March 2025. The company has managed to enhance its operating profit (PBDIT) from Rs 690.00 crore in March 2020 to Rs 2,550.50 crore in March 2025, indicating improved operational efficiency. Profit before tax also saw a substantial increase, moving from Rs 568.70 crore in March 2020 to Rs 2,291.40 crore in March 2025. Consequently, profit after tax surged from Rs 458.10 crore in March 2020 to Rs 1,883.40 crore in March 2025, showcasing a strong profitability trend. The earnings per share (EPS) rose dramatically from Rs 25.32 in March 2020 to Rs 105.33 in March 2025, further emphasizing the company's financial growth. On the balance sheet, total assets increased from Rs 4,303.10 crore in March 2019 to Rs 6,886.90 crore in March 2024, while total liabilities also rose, reflecting the company's expanding operations. Cash flow from operating activities improved significantly, reaching Rs 1,211.00 crore in March 2024, which indicates a healthy cash generation capability. Overall, Natco Pharma's financial performance demonstrates a strong upward trend in sales, profits, and operational efficiency over the analyzed period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
